The enduring success of copyright’s flagship drug has undeniably influenced the healthcare landscape. However, investing in companies heavily reliant on biosimilars and the diminishing patent protection https://bookmark-vip.com/story21488117/the-blue-pill-and-pharmaceutical-companies-a-speculative-venture